Transplantation of Human Fetal Dopamine Cells for Parkinson's Disease
Arch Neurol 47:505-512, Freed,C.R.,et al, 1990
PET Study in Progressive Supranuclear Palsy, Hypometabolic Pattern
Arch Neurol 47:747-752, Blin,J.,et al, 1990
Positron Emission Tomography in Shy-Drager Syndrome
Ann Neurol 28:101-103, Bhatt,M.H.,et al, 1990
A Brain Transplant that Works
Lancet 335:445-446, , 1990
Positron Emission Tomography in Neuropsychiatric Lupus Erythematosus
Neurol 40:304-308, Stoppe,G.,et al, 1990
PET Scanning, Provides Information on Function
BMJ 298:692-694, Frackowiak,R.S.J.&Jones,T., 1989
Normal-Pressure Hydrocephalus and the Saga of the Treatable Dementias
JAMA 262:2577-2581, 2592-25931989., Friedland,R.P., 1989
Cerebral Glucose Metabolism in Wernicke's Broca's, and Conduction Aphasia
Arch Neurol 46:27-34, Metter,E.J.,et al, 1989
Cerebral Glucose Metabolism in the Course of Subacute Sclerosing Panencephalitis
Arch Neurol 46:97-100, Huber,M.,et al, 1989
Cyanide-Induced Parkinsonism:Clinical, MRI, and 6-Fluorodopa PET Studies
Neurol 39:142-144, Rosenberg,N.L.,et al, 1989
Brain Metabolism in Mitochondrial Encephalomyopathy:A PET Study
J Comput Assist Tomogr 12:854-857, DeVolder,A.,et al, 1988
Positron Emission Tomography in a Patient with Progressive Multifocal Leukoencephalopathy
Neurol 38:1864-1867, Kiyosawa,M.,et al, 1988
Surgical Treatment of Intractable Neonatal-Onset Seizures:The Role of Positron Emission Tomography
Neurol 38:1178-1188, Chugani,H.T.,et al, 1988
Positron Emission Tomography-A New Approach to Brain Chemistry
JAMA 260:2704-2710, Jacobson,H.G., 1988
Cerebral Hypometabolism in Progressive Supranuclear Palsy Studied with Positron Emission Tomography
Ann Neurol 24:399-406, Foster,N.L.,et al, 1988
Dementia in Down's Syndrome:Cerebral Glucose Utilization, Neuropsychological Assessment, and Neuropathology
Neurol 38:938-942, Schapiro,M.B.,et al, 1988
Brain Glucose Metabolism in Thalamic Syndrome
JNNP 51:427-428, Laterre,E.C.,et al, 1988
Diagnosis & Treatment of Aphasia, Part I & Part II
JAMA 259:1043-1047, 1205-12101988., Albert,M.L.&Helm-Estabrooks,N., 1988
Disconnection & Cerebral Metabolism, The Case of Conduction Aphasia
Arch Neurol 45:275-279, Kempler,D.,et al, 1988
Cerebellar & Brainstem Hypometabolism in Olivo-pontocerebellar Atrophy Detected with Positron Emission Tomography
Ann Neurol 23:223-230, Gilman,S.,et al, 1988
The Metabolic Pathology of the AIDS Dementia Complex
Ann Neurol 22:700-706, Rottenberg,D.A.,et al, 1987
Positron Emission Tomography Studies of Cerebral Glucose Metabolism in Chronic Partial Epilepsy
Ann Neurol 22:480-486, Abou-Khalil,B.W.,et al, 1987
Borderzone Ischemia
Ann Neurol 22:707-713, Leblanc,R.,et al, 1987
Metabolic & Clinical Correlates of Acute Ischemic Infarction
Neurol 37:1103-1110, Kushner,M.,et al, 1987
The Combined Use of Positron Emission Tomography & DNA Polymorphisms for Preclinical Detection of Huntington's Disease
Neurol 37:1441-1447, Hayden,M.R.,et al, 1987
Wilson's Disease Studies with FDG & Positron Emission Tomography
Neurol 37:1707-1711, Hawkins,R.A.,et al, 1987
Lesions of the Putamen:Their Relevance to Dystonia
Neurol 37:1125-1129, Fross,R.D.,et al, 1987
Differences in Cerebral Blood Flow & Glucose Utilization in Vegetative Versus Locked-in Patients
Ann Neurol 22:673-682, Levy,D.E.,et al, 1987
Response of Human-Immunodeficiency-Virus-Associated Neurological Disease to 3'-Azido-3'-Deoxythymidine
Lancet 1:132-135, Yarchoan,R.,et al, 1987
Normal Caudate Glucose Metabolism in Persons at Risk for Huntington's Disease
Arch Neurol 44:254-257, Young,A.B.,et al, 1987
Reduced Cerebral Glucose Metabolism in Asymptomatic Subjects at Risk for Huntington's Disease
NEJM 316:357-362, Mazziotta,J.C.,et al, 1987
Positron Emission Tomography & Histopathology in Pick's Disease
Neurol 37:439-445, Kamo,H.,et al, 1987
The Lennox-Gastaut Syndrome:Metabolic Subtypes Determined by FDG Positron Emission Tomography
Ann Neurol 21:4-13, Chugani,H.T.,et al, 1987
Cerebral Glucose Metabolism in the Lennox-Gastaut Syndrome
Ann Neurol 21:14-21, Theodore,W.H.,et al, 1987
Primary Progressive Aphasia-Differentiation from Alzheimer's Disease
Ann Neurol 22:533-534, Mesulam,M.M., 1987
Differentiation of Cerebral Radiation Necrosis from Tumor Recurrence by[18F]FDG & 82RB PET Scan
J Comput Assist Tomogr 11:563-570, Doyle,W.K.,et al, 1987
PET, CT, & MR Imaging in Cerebrovascular Disease
J Comput Assist Tomogr 10:903-911, Heiss,W.D.,et al, 1986
PET Scan Investigations of Huntington's Disease:Cerebral Metabolic Corr. of Neuro & Funct Decline
Ann Neurol 20:296-303, Young,A.B.,et al, 1986
Comparison of PET, MRI, & CT with Pathology in a Proven Case of Alzheimer's Disease
Neurol 36:1569-1574, McGeer,P.L.,et al, 1986
Positron Emission Tomography in Dementia of the Alzheimer Type
Arch Int Med 146:2045-2049, Berg,G.,et al, 1986
Brain Dopamine Metabolism in Patients with Parkinson's Disease Measured with Positron Emission Tomography
JNNP 49:853-860, Leenders,K.L.,et al, 1986
Normal Pressure Hydrocephalus
BMJ 293:837-838, Anderson,M., 1986
Slowly Progressive Aphasia without Generalized Dementia:Studies with Positron Emission Tomography
Ann Neurol 19:68-74, Chawluk,J.B.,et al, 1986
Alzheimer's Disease
NEJM 314:964-973, Katzman,R., 1986
PET Studies of Cerebral Glucose Metabolism in Idiopathic Torticollis
Neurol 36:653-657, Stoessl,A.J.,et al, 1986
Positron Emission Tomography in Alzheimer's Disease
Neurol 36:879-887, Duara,R.,et al, 1986
Positron Emission Tomography in the Early Diagnosis of Huntington's Disease
Neurol 36:888-894, Hayden,M.R.,et al, 1986
Magnetic Resonance Imaging in Intractable Partial Epilepsy:Correlative Studies
Ann Neurol 20:57-62, Sperling,M.R.,et al, 1986
Muscarinic Acetylcholine Receptors in Alzheimer's Disease
JAMA 254:3063-3066, Holman,B.L.,et al, 1985
Presentation of Bilateral Thalamic Infarction on CT, MRI & PET
Neuroradiology 27:414-419, Bewermeyer,H.,et al, 1985